Roles of Two Ryanodine Receptor Isoforms Coexisting in Skeletal Muscle

By Murayama T.   Ogawa Y.  

Trends in Cardiovascular Medicine, Vol. 12, Iss. 7, 2002-10 ,pp. : 305-311

Elsevier

Access to resources Recommend Favorite

`Ryanopathy': causes and manifestations of RyR2 dysfunction in heart failure

By Belevych Andriy E.   Radwański Przemysław B.   Carnes Cynthia A.   Györke Sandor  

Cardiovascular Research, Vol. 98, Iss. 2, 2013-05 ,pp. : 240-247

Oxford University Press

Access to resources Recommend Favorite

Hierarchical accumulation of RyR post-translational modifications drives disease progression in dystrophic cardiomyopathy

By Kyrychenko Sergii   Poláková Eva   Kang Chifei   Pocsai Krisztina   Ullrich Nina D.   Niggli Ernst   Shirokova Natalia  

Cardiovascular Research, Vol. 97, Iss. 4, 2013-03 ,pp. : 666-675

Oxford University Press

Access to resources Recommend Favorite

Complement 3 Receptor Expression in Individuals with Type 2 Diabetes

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 11, Iss. 2, 2016-12 ,pp. : 174-182

Bentham Science Publishers

Access to resources Recommend Favorite

Ticagrelor yields consistent dose-dependent inhibition of ADP-induced platelet aggregation in patients with atherosclerotic disease regardless of genotypic variations in P2RY12, P2RY1, and ITGB3

By Storey Robert   Melissa Thornton S.   Lawrance Rachael   Husted Steen   Wickens Mark   Emanuelsson Håkan   Cannon Christopher   Heptinstall Stan   Armstrong Martin  

Platelets, Vol. 20, Iss. 5, 2009-08 ,pp. : 341-348

Informa Healthcare

Access to resources Recommend Favorite